Literature DB >> 19915069

Impaired vasoconstriction and nitric oxide-mediated relaxation in pulmonary arteries of hypoxia- and monocrotaline-induced pulmonary hypertensive rats.

Virak Mam1, Alain F Tanbe, Sally H Vitali, Elena Arons, Helen A Christou, Raouf A Khalil.   

Abstract

Pulmonary hypertension (PH) is a life-threatening disease with unclear vascular mechanisms. We tested whether PH involves abnormal pulmonary vasoconstriction and impaired vasodilation. Male Sprague-Dawley rats were exposed to hypoxia (9% O(2)) for 2 weeks or injected with single dose of monocrotaline (MCT, 60 mg/kg s.c.). Control rats were normoxic or injected with saline. After the hemodynamic measurements were performed, pulmonary and mesenteric arteries were isolated for measurement of vascular function. Hematocrit was elevated in hypoxic rats. Right ventricular systolic pressure and Fulton's Index [right/(left + septum) ventricular weight] were greater in hypoxic and MCT-treated rats than in normoxic rats. Pulmonary artery contraction by phenylephrine and 96 mM KCl was less in hypoxic and MCT-treated rats than in normoxic rats. Acetylcholine-induced relaxation was less in the pulmonary arteries of hypoxic and MCT-treated rats than of normoxic rats, suggesting reduced effects of endothelium-derived vasodilators. The nitric oxide synthase inhibitor, N(omega)-nitro-l-arginine methyl ester, and the guanylate cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, inhibited acetylcholine relaxation, suggesting that it was mediated by nitric oxide (NO)-cGMP. The NO donor sodium nitroprusside caused less relaxation in the pulmonary arteries of hypoxic and MCT-treated than of normoxic rats, suggesting decreased responsiveness of vascular smooth muscle cells (VSMCs) to vasodilators. Phenylephrine and KCl contraction and acetylcholine and sodium nitroprusside relaxation were not different in the mesenteric arteries from all groups. In lung tissue sections, the wall thickness of pulmonary arterioles was greater in hypoxic and MCT-treated rats than in normoxic rats. The specific reductions in pulmonary, but not systemic, arterial vasoconstriction and vasodilation in hypoxia- and MCT-induced PH are consistent with the possibility of de-differentiation of pulmonary VSMCs to a more proliferative/synthetic and less contractile phenotype in PH.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915069      PMCID: PMC2812110          DOI: 10.1124/jpet.109.160119

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  40 in total

1.  Hypoxia and hypoxia-inducible factor-1alpha promote growth factor-induced proliferation of human vascular smooth muscle cells.

Authors:  Kelly Schultz; Barry L Fanburg; Debbie Beasley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-01-06       Impact factor: 4.733

2.  Reversal of experimental pulmonary hypertension by PDGF inhibition.

Authors:  Ralph Theo Schermuly; Eva Dony; Hossein Ardeschir Ghofrani; Soni Pullamsetti; Rajkumar Savai; Markus Roth; Akylbek Sydykov; Ying Ju Lai; Norbert Weissmann; Werner Seeger; Friedrich Grimminger
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement.

Authors:  Khalil Fattouch; Fabrizio Sbraga; Giuseppe Bianco; Giuseppe Speziale; Marco Gucciardo; Roberto Sampognaro; Giovanni Ruvolo
Journal:  J Card Surg       Date:  2005 Mar-Apr       Impact factor: 1.620

4.  Hyporeactivity of rat diaphragmatic arterioles after exposure to hypoxia in vivo. Role of the endothelium.

Authors:  M Toporsian; M E Ward
Journal:  Am J Respir Crit Care Med       Date:  1997-11       Impact factor: 21.405

5.  Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling.

Authors:  Namasivayam Ambalavanan; Arlene Bulger; Joanne Murphy-Ullrich; Suzanne Oparil; Yiu-Fai Chen
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

6.  Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats.

Authors:  H Itoh; A Yokochi; R Yamauchi-Kohno; K Maruyama
Journal:  Eur J Pharmacol       Date:  1999-07-09       Impact factor: 4.432

7.  Hypoxia stimulates proliferation and interleukin-1alpha production in human vascular smooth muscle cells.

Authors:  A L Cooper; D Beasley
Journal:  Am J Physiol       Date:  1999-10

8.  Impaired reactivity of rat aorta to phenylephrine and KCl after prolonged hypoxia: role of the endothelium.

Authors:  G Auer; M E Ward
Journal:  J Appl Physiol (1985)       Date:  1998-08

9.  Pulmonary hypertensive crises following surgery for congenital heart defects in young children.

Authors:  R A Hopkins; C Bull; S G Haworth; M R de Leval; J Stark
Journal:  Eur J Cardiothorac Surg       Date:  1991       Impact factor: 4.191

10.  Changes in regional blood flow distribution and oxygen supply during hypoxia in conscious rats.

Authors:  I Kuwahira; N C Gonzalez; N Heisler; J Piiper
Journal:  J Appl Physiol (1985)       Date:  1993-01
View more
  31 in total

1.  Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.

Authors:  Helen Christou; Ossama M Reslan; Virak Mam; Alain F Tanbe; Sally H Vitali; Marlin Touma; Elena Arons; S Alex Mitsialis; Stella Kourembanas; Raouf A Khalil
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-27       Impact factor: 5.464

2.  Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension.

Authors:  Zhiyuan Ma; Lan Mao; Sudarshan Rajagopal
Journal:  J Vis Exp       Date:  2016-04-11       Impact factor: 1.355

3.  Exogenous ghrelin improves blood flow distribution in pulmonary hypertension-assessed using synchrotron radiation microangiography.

Authors:  Daryl O Schwenke; Emily A Gray; James T Pearson; Takashi Sonobe; Hatsue Ishibashi-Ueda; Isabel Campillo; Kenji Kangawa; Keiji Umetani; Mikiyasu Shirai
Journal:  Pflugers Arch       Date:  2011-07-09       Impact factor: 3.657

4.  Pluripotent hematopoietic stem cells augment α-adrenergic receptor-mediated contraction of pulmonary artery and contribute to the pathogenesis of pulmonary hypertension.

Authors:  Ryota Hashimoto; Gregg M Lanier; Vidhi Dhagia; Sachindra R Joshi; Allan Jordan; Ian Waddell; Rubin Tuder; Kurt R Stenmark; Michael S Wolin; Ivan F McMurtry; Sachin A Gupte
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-08       Impact factor: 5.464

5.  Sex hormones and vascular protection in pulmonary arterial hypertension.

Authors:  Helen A Christou; Raouf A Khalil
Journal:  J Cardiovasc Pharmacol       Date:  2010-11       Impact factor: 3.105

Review 6.  Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Authors:  A Dasgupta; L Bowman; C L D'Arsigny; S L Archer
Journal:  Clin Pharmacol Ther       Date:  2014-11-28       Impact factor: 6.875

7.  A Ca²⁺-dependent chloride current and Ca²⁺ influx via Ca(v)1.2 ion channels play major roles in P2Y receptor-mediated pulmonary vasoconstriction.

Authors:  Callum Mitchell; Nawazish-i-Husain Syed; Alison M Gurney; Charles Kennedy
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

8.  Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.

Authors:  Helen Christou; Hannes Hudalla; Zoe Michael; Evgenia J Filatava; Jun Li; Minglin Zhu; Jose S Possomato-Vieira; Carlos Dias-Junior; Stella Kourembanas; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2017-12-06       Impact factor: 4.030

9.  Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.

Authors:  Arnica Behringer; Manuela Trappiel; Eva Maria Berghausen; Henrik Ten Freyhaus; Ernst Wellnhofer; Margarete Odenthal; Florian Blaschke; Fikret Er; Natig Gassanov; Stephan Rosenkranz; Stephan Baldus; Kai Kappert; Evren Caglayan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-07       Impact factor: 3.000

10.  17β-Estradiol Attenuates Conduit Pulmonary Artery Mechanical Property Changes With Pulmonary Arterial Hypertension.

Authors:  Aiping Liu; Lian Tian; Mark Golob; Jens C Eickhoff; Madison Boston; Naomi C Chesler
Journal:  Hypertension       Date:  2015-09-21       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.